Riskpilot← Back to searchSign inGet full accessNordic Eucaliv Apoteket AB
ABIn liquidationOrg 5591424931Retail sale of tobacco products · NACE 4726Est. 20170 employees
Revenue 2024
SEK 5K
EBITDA margin
73.7%
+104% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 121K
-41% vs 2023
| Revenue | SEK 5K | — |
| EBITDA | SEK 4K | +104% |
| Net profit | SEK 121K | -41% |
| Total assets | SEK 3K | -100% |
| Equity | SEK 3K | -99% |
| Employees | 0 | — |
Legal name
Nordic Eucaliv Apoteket AB
Org number
5591424931
Legal form
Aktiebolag
NACE code
4726 · Retail sale of tobacco products
Founded
27 december 2017
Share capital
SEK 150 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Företaget ska bedriva apotekshandel, hälsokost och kosmetika och därmed förenlig verksamhet.
Address
Email
liai@swedhan.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 42 | 5 | 0 | 0 | 5 |
| Staff expenses | — | — | −0 | — | — |
| EBITDA | −768 | −1 235 | −386 | −95 | 4 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −768 | −1 235 | −386 | −95 | −1 |
| Net financials | 569 | 850 | 0 | 300 | 122 |
| Profit before tax | −179 | −386 | 4 | 205 | 121 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −179 | −386 | 4 | 205 | 121 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 371 | 2 024 | 2 355 | 2 564 | 3 |
| Equity | 153 | 147 | 152 | 356 | 3 |
| Long-term debt | 1 148 | 1 870 | 2 197 | 2 205 | 0 |
| Short-term debt | 70 | 6 | 6 | 3 | 0 |
| Total debt | 1 218 | 1 876 | 2 203 | 2 208 | — |
EBITDA margin
73.7%
This company
15.8%
Market median
+366% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
3953.1%
This company
18.4%
Market median
+21384% vs market
20202024
Net profit margin
2215.1%
This company
8.1%
Market median
+27247% vs market
20202024
Asset turnover
1.78×
This company
1.12×
Market median
+59% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LA Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
KJ | Board of Directors | 2022 – 2025 |
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2023 | |
JY | Deputy Board Member | 2022 – 2023 |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordic Eucaliv Apoteket AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Li Ai | Liquidator | 0 companies |
| Kang Jin | Board of Directors | 0 companies |
| Jian Huang | Deputy Board Member | 0 companies |
| Guan Wang | Deputy Board Member | 0 companies |
| Juan Yu | Deputy Board Member | 0 companies |